Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB-ADAZ Cause Product dose omission issue? 562 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 562 reports of Product dose omission issue have been filed in association with ADALIMUMAB-ADAZ. This represents 8.1% of all adverse event reports for ADALIMUMAB-ADAZ.

562
Reports of Product dose omission issue with ADALIMUMAB-ADAZ
8.1%
of all ADALIMUMAB-ADAZ reports
13
Deaths
137
Hospitalizations

How Dangerous Is Product dose omission issue From ADALIMUMAB-ADAZ?

Of the 562 reports, 13 (2.3%) resulted in death, 137 (24.4%) required hospitalization, and 8 (1.4%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-ADAZ. However, 562 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB-ADAZ Cause?

Drug ineffective (928) Off label use (925) Fatigue (798) Arthralgia (787) Pain (735) Diarrhoea (721) General physical health deterioration (597) Malaise (566) Rheumatoid arthritis (506) Abdominal pain (482)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which ADALIMUMAB-ADAZ Alternatives Have Lower Product dose omission issue Risk?

ADALIMUMAB-ADAZ vs ADALIMUMAB-ADBM ADALIMUMAB-ADAZ vs ADALIMUMAB-AFZB ADALIMUMAB-ADAZ vs ADALIMUMAB-ATTO ADALIMUMAB-ADAZ vs ADALIMUMAB-BWWD ADALIMUMAB-ADAZ vs ADALIMUMAB-FKJP

Related Pages

ADALIMUMAB-ADAZ Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue ADALIMUMAB-ADAZ Demographics